BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kaleka G, Schiller G. Immunotherapy for Acute Myeloid Leukemia: Allogeneic hematopoietic cell transplantation is here to stay. Leuk Res 2021;112:106732. [PMID: 34864447 DOI: 10.1016/j.leukres.2021.106732] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Xu CL, Chen Y, Zhu TT, Sun ZJ, Chu JH. [Clinical significance and pathogenesis analysis of heterogeneous nuclear ribonucleoprotein U in acute myeloid leukemia]. Zhonghua Xue Ye Xue Za Zhi 2022;43:745-52. [PMID: 36709168 DOI: 10.3760/cma.j.issn.0253-2727.2022.09.006] [Reference Citation Analysis]
2 Sugimoto E, Hayashi Y, Iida K, Asada S, Fukushima T, Tamura M, Kawabata K, Kawase T, Saito T, Yoshida T, Yamazaki S, Kaito Y, Imai Y, Fukuyama T, Tanaka Y, Enomoto Y, Kitamura T, Goyama S. Hyperactive NK cells in Rag2 knockout mice inhibit the development of acute myeloid leukemia.. [DOI: 10.21203/rs.3.rs-1934697/v1] [Reference Citation Analysis]